Publications

• 1. Nozaki Y
  2. Hao Y
  3. Barnas JL
  Editorial: Treat-to-target in systemic lupus erythematosus: cytokine transduction pathways in SLE.; Frontiers in immunology; Vol 15, pp. 1503776. 2024 Oct 16.
• 1. Sakaue S
  2. Weinand K
  3. Isaac S
  4. Dey KK
  5. Jagadeesh K
  6. Kanai M
  7. Watts GFM
  8. Zhu Z
  9. Brenner MB
  10. McDavid A
  11. Donlin LT
  12. Wei K
  13. Price AL
  14. Raychaudhuri S
  Tissue-specific enhancer-gene maps from multimodal single-cell data identify causal disease alleles.; Nature genetics. 2024 Apr 09.
• 1. Carlucci PM
  2. Preisinger K
  3. Deonaraine KK
  4. Zaminski D
  5. Dall'Era M
  6. Gold HT
  7. Kalunian K
  8. Fava A
  9. Belmont HM
  10. Wu M
  11. Putterman C
  12. Anolik J
  13. Barnas JL
  14. Furie R
  15. Diamond B
  16. Davidson A
  17. Wofsy D
  18. Kamen D
  19. James JA
  20. Guthridge JM
  21. Apruzzese W
  22. Rao D
  23. Weisman MH
  24. Izmirly PM
  25. Buyon J
  26. Petri M
  Extrarenal symptoms associate with worse quality of life in patients enrolled in the AMP RA/SLE Lupus Nephritis Network.; Rheumatology (Oxford, England). 2024 Mar 26.
• 1. Izmirly PM
  2. Kim MY
  3. Carlucci PM
  4. Preisinger K
  5. Cohen BZ
  6. Deonaraine K
  7. Zaminski D
  8. Dall'Era M
  9. Kalunian K
  10. Fava A
  11. Belmont HM
  12. Wu M
  13. Putterman C
  14. Anolik J
  15. Barnas JL
  16. Diamond B
  17. Davidson A
  18. Wofsy D
  19. Kamen D
  20. James JA
  21. Guthridge JM
  22. Apruzzese W
  23. Rao DA
  24. Weisman MH
  25. Petri M
  26. Buyon J
  27. Furie R
  Longitudinal patterns and predictors of response to standard-of-care therapy in lupus nephritis: data from the Accelerating Medicines Partnership Lupus Network.; Arthritis research & therapy; Vol 26(1), pp. 54. 2024 Feb 20.
• 1. Fava A
  2. Buyon J
  3. Magder L
  4. Hodgin J
  5. Rosenberg A
  6. Demeke DS
  7. Rao DA
  8. Arazi A
  9. Celia AI
  10. Putterman C
  11. Anolik JH
  12. Barnas J
  13. Dall'Era M
  14. Wofsy D
  15. Furie R
  16. Kamen D
  17. Kalunian K
  18. James JA
  19. Guthridge J
  20. Atta MG
  21. Monroy Trujillo J
  22. Fine D
  23. Clancy R
  24. Belmont HM
  25. Izmirly P
  26. Apruzzese W
  27. Goldman D
  28. Berthier CC
  29. Hoover P
  30. Hacohen N
  31. Raychaudhuri S
  32. Davidson A
  33. Diamond B
  34. Petri M
  Urine proteomic signatures of histological class, activity, chronicity, and treatment response in lupus nephritis.; JCI insight; Vol 9(2). 2024 Jan 23.
• 1. Horisberger A
  2. Griffith A
  3. Keegan J
  4. Arazi A
  5. Pulford J
  6. Murzin E
  7. Howard K
  8. Hancock B
  9. Fava A
  10. Sasaki T
  11. Ghosh T
  12. Inamo J
  13. Beuschel R
  14. Cao Y
  15. Preisinger K
  16. Gutierrez-Arcelus M
  17. Eisenhaure TM
  18. Guthridge J
  19. Hoover PJ
  20. Dall'Era M
  21. Wofsy D
  22. Kamen DL
  23. Kalunian KC
  24. Furie R
  25. Belmont M
  26. Izmirly P
  27. Clancy R
  28. Hildeman D
  29. Woodle ES
  30. Apruzzese W
  31. McMahon MA
  32. Grossman J
  33. Barnas JL
  34. Payan-Schober F
  35. Ishimori M
  36. Weisman M
  37. Kretzler M
  38. Berthier CC
  39. Hodgin JB
  40. Demeke DS
  41. Putterman C
  42. Brenner MB
  43. Anolik JH
  44. Raychaudhuri S
  45. Hacohen N
  46. James JA
  47. Davidson A
  48. Petri MA
  49. Buyon JP
  50. Diamond B
  51. Zhang F
  52. Lederer JA
  53. Rao DA
  Blood immunophenotyping identifies distinct kidney histopathology and outcomes in patients with lupus nephritis.; bioRxiv : the preprint server for biology. 2024 Jan 15.
• 1. Zhang F
  2. Jonsson AH
  3. Nathan A
  4. Millard N
  5. Curtis M
  6. Xiao Q
  7. Gutierrez-Arcelus M
  8. Apruzzese W
  9. Watts GFM
  10. Weisenfeld D
  11. Nayar S
  12. Rangel-Moreno J
  13. Meednu N
  14. Marks KE
  15. Mantel I
  16. Kang JB
  17. Rumker L
  18. Mears J
  19. Slowikowski K
  20. Weinand K
  21. Orange DE
  22. Geraldino-Pardilla L
  23. Deane KD
  24. Tabechian D
  25. Ceponis A
  26. Firestein GS
  27. Maybury M
  28. Sahbudin I
  29. Ben-Artzi A
  30. Mandelin AM
  31. Nerviani A
  32. Lewis MJ
  33. Rivellese F
  34. Pitzalis C
  35. Hughes LB
  36. Horowitz D
  37. DiCarlo E
  38. Gravallese EM
  39. Boyce BF
  40. Moreland LW
  41. Goodman SM
  42. Perlman H
  43. Holers VM
  44. Liao KP
  45. Filer A
  46. Bykerk VP
  47. Wei K
  48. Rao DA
  49. Donlin LT
  50. Anolik JH
  51. Brenner MB
  52. Raychaudhuri S
  Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes.; Nature; Vol 623(7987), pp. 616-624. 2023 Nov 08.
• 1. Carlucci PM
  2. Li J
  3. Fava A
  4. Deonaraine KK
  5. Wofsy D
  6. James JA
  7. Putterman C
  8. Diamond B
  9. Davidson A
  10. Fine DM
  11. Monroy-Trujillo J
  12. Atta MG
  13. DeJager W
  14. Guthridge JM
  15. Haag K
  16. Rao DA
  17. Brenner MB
  18. Lederer JA
  19. Apruzzese W
  20. Belmont HM
  21. Izmirly PM
  22. Zaminski D
  23. Wu M
  24. Connery S
  25. Payan-Schober F
  26. Furie R
  27. Dall'Era M
  28. Cho K
  29. Kamen D
  30. Kalunian K
  31. Anolik J
  32. Barnas J
  33. Ishimori M
  34. Weisman MH
  35. Buyon JP
  36. Petri M
  High incidence of proliferative and membranous nephritis in SLE patients with low proteinuria in the Accelerating Medicines Partnership.; Rheumatology (Oxford, England). 2022 Feb 25.
• 1. Carlucci P
  2. Li J
  3. Fava A
  4. Deonaraine K
  5. Wofsy D
  6. James J
  7. Putterman C
  8. Diamond B
  9. Davidson A
  10. Fine D
  11. Monroy-Trujillo J
  12. Atta M
  13. DeJager W
  14. Guthridge J
  15. Haag K
  16. Rao D
  17. Bernner M
  18. Lederer J
  19. Apruzzese W
  20. Belmont M
  21. Izmirly P
  22. Wu M
  23. Connery S
  24. Payan-Schober F
  25. Furie R
  26. Dall'Era M
  27. Cho K
  28. Kamen D
  29. Kalunian K
  30. Anolik J
  31. Barnas J
  32. Ishimori M
  33. Weisman M
  34. Buyon J
  35. Petri M
  High incidence of clinically actionable kidney histology in SLE patients with low proteinuria in the Accelerating Medicines Partnership; Rheumatology; Vol (accepted). 2022 Jan 01.
• 1. Barnas JL
  2. Albrecht J
  3. Meednu N
  4. Alzamareh DF
  5. Baker C
  6. McDavid A
  7. Looney RJ
  8. Anolik JH
  B Cell Activation and Plasma Cell Differentiation Are Promoted by IFN-λ in Systemic Lupus Erythematosus.; Journal of immunology (Baltimore, Md. : 1950). 2021 Oct 27.
• 1. Deonaraine KK
  2. Carlucci PM
  3. Fava A
  4. Li J
  5. Wofsy D
  6. James JA
  7. Putterman C
  8. Diamond B
  9. Davidson A
  10. Fine DM
  11. Monroy-Trujillo J
  12. Atta MG
  13. Haag K
  14. Rao DA
  15. Apruzzese W
  16. Belmont HM
  17. Izmirly PM
  18. Wu M
  19. Connery S
  20. Payan-Schober F
  21. Furie RA
  22. Berthier CC
  23. Dall'Era M
  24. Cho K
  25. Kamen DL
  26. Kalunian K
  27. Anolik J
  28. Ishimori M
  29. Weisman MH
  30. Petri MA
  31. Buyon JP
  Safety of procuring research tissue during a clinically indicated kidney biopsy from patients with lupus: data from the Accelerating Medicines Partnership RA/SLE Network.; Lupus science & medicine; Vol 8(1). 2021 Aug.
• 1. Barnas JL
  2. Looney RJ
  3. Anolik JH
  B cell targeted therapies in autoimmune disease.; Current opinion in immunology; Vol 61. 2019 Dec.
• 1. Dieudonné Y
  2. Gies V
  3. Guffroy A
  4. Keime C
  5. Bird AK
  6. Liesveld J
  7. Barnas JL
  8. Poindron V
  9. Douiri N
  10. Soulas-Sprauel P
  11. Martin T
  12. Meffre E
  13. Anolik JH
  14. Korganow AS
  Transitional B cells in quiescent SLE: An early checkpoint imprinted by IFN.; Journal of autoimmunity; Vol 102. 2019 Aug.
• 1. Gao L
  2. Slack M
  3. Barnas JL
  4. McDavid A
  5. Anolik J
  6. Looney RJ
  Correction to: Cell Senescence in Lupus.; Current rheumatology reports; Vol 21(7). 2019 May 23.
• 1. Barnas JL
  2. Ritchlin CT
  Etiology and Pathogenesis of Psoriatic Arthritis.; Rheumatic diseases clinics of North America; Vol 41(4). 2015 Nov.
• 1. Simpson-Abelson MR
  2. Loyall JL
  3. Lehman HK
  4. Barnas JL
  5. Minderman H
  6. O'Loughlin KL
  7. Wallace PK
  8. George TC
  9. Peng P
  10. Kelleher RJ
  11. Odunsi K
  12. Bankert RB
  Human ovarian tumor ascites fluids rapidly and reversibly inhibit T cell receptor-induced NF-κB and NFAT signaling in tumor-associated T cells.; Cancer immunity; Vol 13. 2013.
• 1. Bankert RB
  2. Balu-Iyer SV
  3. Odunsi K
  4. Shultz LD
  5. Kelleher RJ
  6. Barnas JL
  7. Simpson-Abelson M
  8. Parsons R
  9. Yokota SJ
  Humanized mouse model of ovarian cancer recapitulates patient solid tumor progression, ascites formation, and metastasis.; PloS one; Vol 6(9). 2011.
• 1. Mulhall JP
  2. Barnas J
  3. Kobylarz K
  4. Mueller A
  p53-Associated Parkin-like cytoplasmic protein (Parc) short-interfering RNA (siRNA) alters p53 location and biology of Peyronie's disease fibroblasts.; BJU international; Vol 106(11). 2010 Dec.
• 1. Barnas JL
  2. Simpson-Abelson MR
  3. Brooks SP
  4. Kelleher RJ
  5. Bankert RB
  Reciprocal functional modulation of the activation of T lymphocytes and fibroblasts derived from human solid tumors.; Journal of immunology (Baltimore, Md. : 1950); Vol 185(5). 2010 Sep 01.
• 1. Barnas JL
  2. Simpson-Abelson MR
  3. Yokota SJ
  4. Kelleher RJ
  5. Bankert RB
  T cells and stromal fibroblasts in human tumor microenvironments represent potential therapeutic targets.; Cancer microenvironment : official journal of the International Cancer Microenvironment Society; Vol 3(1). 2010 Mar 31.
• 1. Mulhall J
  2. Teloken P
  3. Barnas J
  Vasculogenic erectile dysfunction is a predictor of abnormal stress echocardiography.; The journal of sexual medicine; Vol 6(3). 2009 Mar.
• 1. Barnas J
  2. Parker M
  3. Guhring P
  4. Mulhall JP
  The utility of tamsulosin in the management of orgasm-associated pain: a pilot analysis.; European urology; Vol 47(3). 2005 Mar.
• 1. Brooks MB
  2. Barnas JL
  3. Fremont J
  4. Ray J
  Cosegregation of a factor VIII microsatellite marker with mild hemophilia A in Golden Retriever dogs.; Journal of veterinary internal medicine; Vol 19(2). 2005 Mar.
• 1. Mulhall J
  2. Barnas J
  3. Aviv N
  4. Anderson M
  5. Parker M
  Sildenafil citrate response correlates with the nature and the severity of penile vascular insufficiency.; The journal of sexual medicine; Vol 2(1). 2005 Jan.
• 1. Barnas JL
  2. Pierpaoli S
  3. Ladd P
  4. Valenzuela R
  5. Aviv N
  6. Parker M
  7. Waters WB
  8. Flanigan RC
  9. Mulhall JP
  The prevalence and nature of orgasmic dysfunction after radical prostatectomy.; BJU international; Vol 94(4). 2004 Sep.
• 1. Brooks MB
  2. Gu W
  3. Barnas JL
  4. Ray J
  5. Ray K
  A Line 1 insertion in the Factor IX gene segregates with mild hemophilia B in dogs.; Mammalian genome : official journal of the International Mammalian Genome Society; Vol 14(11). 2003 Nov.